Published in J Clin Microbiol on November 24, 2010
Potential sexual transmission of Zika virus. Emerg Infect Dis (2015) 5.86
Detection of chikungunya virus in saliva and urine. Virol J (2016) 1.42
Isolation of Infective Zika Virus from Urine and Saliva of Patients in Brazil. PLoS Negl Trop Dis (2016) 1.30
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
Rapid molecular assays for the detection of yellow fever virus in low-resource settings. PLoS Negl Trop Dis (2014) 0.98
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother (2013) 0.96
First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One (2012) 0.87
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus. Viruses (2013) 0.87
Evaluation of two molecular methods for the detection of Yellow fever virus genome. J Virol Methods (2011) 0.85
Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment. Vaccine (2014) 0.84
Questions regarding the safety and duration of immunity following live yellow fever vaccination. Expert Rev Vaccines (2016) 0.80
Viral hemorrhagic fevers: advancing the level of treatment. BMC Med (2012) 0.80
Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLoS Pathog (2015) 0.78
Serious adverse events associated with yellow fever vaccine. Hum Vaccin Immunother (2015) 0.77
Yellow Fever 17DD Vaccine Virus Infection Causes Detectable Changes in Chicken Embryos. PLoS Negl Trop Dis (2015) 0.77
Detection of tick-borne encephalitis virus RNA in urine. J Clin Microbiol (2014) 0.76
Urine as sample for molecular diagnosis of natural yellow fever virus infections. J Clin Microbiol (2017) 0.75
Yellow fever: an update. Lancet Infect Dis (2001) 3.18
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2010) 2.00
Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol (1998) 1.90
West Nile virus detection in urine. Emerg Infect Dis (2005) 1.76
Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods (2003) 1.54
Detection of dengue virus in saliva and urine by real time RT-PCR. Virol J (2010) 1.36
Antigenuria in St. Louis encephalitis. Am J Trop Med Hyg (1980) 1.34
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
Confirmation of dengue virus infection by detection of dengue virus type 1 genome in urine and saliva but not in plasma. Trans R Soc Trop Med Hyg (2007) 1.24
Viruria during acute Japanese encephalitis virus infection. Int J Exp Pathol (1995) 1.23
Yellow fever vaccine-associated viscerotropic disease and death in Spain. J Clin Virol (2006) 1.21
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine (2007) 1.13
Yellow fever: 100 years of discovery. JAMA (2008) 1.07
Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart. Pathol Res Pract (1992) 1.02
Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med (2008) 0.95
Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys. An Acad Bras Cienc (2008) 0.84
Jungle yellow fever: clinical and laboratorial studies emphasizing viremia on a human case. Rev Inst Med Trop Sao Paulo (1996) 0.81
Leishmaniasis and poverty. Trends Parasitol (2006) 4.25
Comparative role of Aedes albopictus and Aedes aegypti in the emergence of Dengue and Chikungunya in central Africa. Vector Borne Zoonotic Dis (2010) 2.18
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect (2002) 1.64
A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther (2010) 1.61
Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods (2003) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods (2007) 1.49
Alkhumra, not Alkhurma, is the correct name of the new hemorrhagic fever flavivirus identified in Saudi Arabia. Intervirology (2012) 1.48
Multicentre evaluation of central nervous system infections due to Flavi and Phleboviruses in Turkey. J Infect (2012) 1.43
Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon. BMC Res Notes (2013) 1.40
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta Trop (2004) 1.39
West Nile virus in Spain: report of the first diagnosed case (in Spain) in a human with aseptic meningitis. Scand J Infect Dis (2007) 1.35
2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis (2010) 1.34
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol (2010) 1.27
Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods (2008) 1.26
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
West Nile virus past infections in the general population of Southern Spain. Enferm Infecc Microbiol Clin (2007) 1.23
Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res (2008) 1.19
Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol (2004) 1.14
Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg (2007) 1.12
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol (2015) 1.11
Human West Nile virus infection, Catalonia, Spain. Emerg Infect Dis (2006) 1.11
External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol (2004) 1.09
Factors affecting patterns of tick parasitism on forest rodents in tick-borne encephalitis risk areas, Germany. Parasitol Res (2010) 1.09
Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. J Infect (2010) 1.08
SARS molecular detection external quality assurance. Emerg Infect Dis (2004) 1.08
Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg (2013) 1.06
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine (2006) 1.05
Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol (2003) 1.05
Tick burden on European roe deer (Capreolus capreolus). Exp Appl Acarol (2010) 1.05
SARS transmission and commercial aircraft. Emerg Infect Dis (2004) 1.04
Phylogenetic history demonstrates two different lineages of dengue type 1 virus in Colombia. Virol J (2010) 1.03
Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis (2009) 1.03
Simultaneous circulation of genotypes I and III of dengue virus 3 in Colombia. Virol J (2008) 1.02
Type 1 diabetes in Swedish bank voles (Clethrionomys glareolus): signs of disease in both colonized and wild cyclic populations at peak density. Ann N Y Acad Sci (2003) 1.00
Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill (2015) 0.97
West Nile virus monitoring of migratory and resident birds in Germany. Vector Borne Zoonotic Dis (2010) 0.97
Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis (2009) 0.97
High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol (2004) 0.96
First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis (2012) 0.96
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J Infect Dis (2008) 0.96
Dengue antibody prevalence in German travelers. Emerg Infect Dis (2005) 0.96
Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis (2004) 0.95
A new quantitative real-time reverse transcriptase PCR assay and melting curve analysis for detection and genotyping of Ljungan virus strains. J Virol Methods (2006) 0.95
CD40L expression permits CD8+ T cells to execute immunologic helper functions. Blood (2013) 0.95
Yellow fever-associated viscerotropic disease in Barcelona, Spain. J Travel Med (2008) 0.95
Rickettsia aeschlimannii in Hyalomma marginatum ticks, Germany. Emerg Infect Dis (2011) 0.94
Impact of cyfluthrin (Solfac EW050) impregnated bed nets on malaria transmission in the city of Mbandjock : lessons for the nationwide distribution of long-lasting insecticidal nets (LLINs) in Cameroon. Parasit Vectors (2013) 0.94
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2012) 0.94
Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis (2014) 0.93
Safety of 17D derived yellow fever vaccines. Expert Opin Drug Saf (2009) 0.92
Rodents as sentinels for the prevalence of tick-borne encephalitis virus. Vector Borne Zoonotic Dis (2011) 0.92
Evaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccination. PLoS Negl Trop Dis (2010) 0.92
Molecular surveillance of circulating dengue genotypes through European travelers. J Travel Med (2011) 0.92
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses (2013) 0.91
Performance of various commercial assays for the detection of Toscana virus antibodies. Vector Borne Zoonotic Dis (2011) 0.90
Determinants of tick-borne encephalitis in counties of southern Germany, 2001-2008. Int J Health Geogr (2010) 0.89
Second external quality assessment of the molecular diagnostic of West Nile virus: are there improvements towards the detection of WNV? J Clin Virol (2011) 0.89
Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity. Virus Genes (2005) 0.88
Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol J (2013) 0.88
Quality control assessment for the PCR diagnosis of tick-borne encephalitis virus infections. J Clin Virol (2006) 0.88
Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol (2004) 0.88
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review. Expert Rev Vaccines (2013) 0.88
International external quality assessment of molecular detection of Rift Valley fever virus. PLoS Negl Trop Dis (2013) 0.88
Phylogenetic reconstruction of dengue virus type 2 in Colombia. Virol J (2012) 0.87
Oligomerization of Uukuniemi virus nucleocapsid protein. Virol J (2010) 0.87
First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One (2012) 0.87
Chikungunya fever in Israeli travelers returning from northwestern India. J Travel Med (2008) 0.87
Quality control measures for the serological diagnosis of hantavirus infections. J Clin Virol (2003) 0.87
The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol (2012) 0.86
Detection and differentiation of tick-borne encephalitis virus subtypes by a reverse transcription quantitative real-time PCR and pyrosequencing. J Virol Methods (2010) 0.86
Diagnosis of tick-borne encephalitis by a mu-capture immunoglobulin M-enzyme immunoassay based on secreted recombinant antigen produced in insect cells. J Clin Microbiol (2003) 0.86
Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa. J Virol (2012) 0.86
Second external quality assurance study for the serological diagnosis of hantaviruses in Europe. PLoS Negl Trop Dis (2012) 0.86
West Nile virus monitoring in migrating and resident water birds in Iran: are common coots the main reservoirs of the virus in wetlands? Vector Borne Zoonotic Dis (2011) 0.85
Tickborne encephalitis virus antibodies in wild cervids in Belgium. Vet Rec (2012) 0.85
The phylogeny of yellow fever virus 17D vaccines. Vaccine (2011) 0.85
Medical importance of Sindbis virus in south-west Germany. J Clin Virol (2011) 0.85
[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey]. Mikrobiyol Bul (2010) 0.84
Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein. Virol J (2010) 0.84
Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosis of SARS. J Med Virol (2005) 0.83
Combination of hypoxia and RNA-interference targeting VEGF induces apoptosis in hepatoma cells via autocrine mechanisms. Curr Pharm Biotechnol (2012) 0.82
Clinical features and pitfalls in the laboratory diagnosis of dengue in travellers. BMC Infect Dis (2006) 0.82
Antibody responses in humans infected with newly emerging strains of West Nile Virus in Europe. PLoS One (2013) 0.82
rapidSTRIPE H1N1 test for detection of the pandemic swine origin influenza A (H1N1) virus. J Clin Microbiol (2011) 0.82
Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis (2013) 0.82
Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali. Trans R Soc Trop Med Hyg (2012) 0.82
[Microbiological diagnosis of chikungunya virus in Spain (2006-2007): case detection in travelers]. Enferm Infecc Microbiol Clin (2009) 0.82
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review. Vaccine (2013) 0.81
SARS coronavirus detection. Emerg Infect Dis (2004) 0.81
Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway. Biol Chem (2007) 0.80